Forgot Password?
Return to Course Listing

CME: Binge eating disorder (BED): therapeutic updates, best practices, and barriers to care

Activity Description / Statement of Need:

In this online, self-learning activity:

Binge eating disorder is defined as eating significantly more food than most people would in a similar period of time at an average frequency of at least once a week for three months and without the compensatory mechanisms associated with other eating disorders (e.g., purging). This disorder was first described in obese individuals as early as 1959 but did not become a formal diagnosis until the 1990s and was not formally added to the DSM of Mental Disorders as a distinct classification until the 5th edition. Episodes of binge eating are associated with a lack of control and with distress over eating patterns. BED puts people at an increased risk of developing future chronic pain, diabetes mellitus, and hypertension; those with BED are also more likely to have a higher body mass index and be categorized as obese.

Target Audience:

The following healthcare professionals: psychiatrists and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists who practice in psychiatry; and any other healthcare professionals with an interest in or who clinically encounter patients with BED.


This program is supported by an educational grant from Shire.


Release Date: September 04, 2018 -- Expiration Date: September 04, 2020

Faculty: Terry Schwartz,

Agenda

BED’s epidemiology, comorbidities, presentation, and diagnosis

  • Historical perspective and evolution as a disorder from eating disorder, NOS
  • Statistics
  • Psychosocial factors
  • Clinical features
    • Depression, obesity, cardiovascular disease, type 2 diabetes, gastroesophageal reflux disease (GERD) and substance use disorders
  • Diagnostic methods
  • Clinical presentation, physical exam, blood and urinalysis, sleep disorder consultation
  • DSM-5 diagnostic criteria
  • Comorbid neuropsychiatric conditions and differential diagnosis
  • Patient case(s)

BED treatment

  • Non-pharmacotherapy
    • Psychological therapy
    • Behavioral weight loss therapy
  • Pharmacotherapy: present and investigational therapies
  • Approved: lisdexamfetamine
  • Off-label
  • Investigational: dasotraline
  • Clinical pearls and emerging practices
  • Best practice: putting it all together
  • Patient case(s)
  • Supportive care
  • Barriers to optimal care and solutions

Learning Objectives

By the end of the session the participant will be able to:

  • Describe the importance of accurate diagnosis and treatment of BED.
  • Determine likelihood of BED using established methods in a patient case.
  • Describe available therapies used for treatment of BED and summarize* recent literature supporting use of those therapies
  • Design a therapeutic regimen, including pharmacotherapy, for the treatment of BED
  • Describe barriers preventing the optimal treatment of BED

Accreditation

THIS COURSE IS EXPIRED. NO CREDIT WILL BE ISSUED.


Faculty Disclosure and Resolution of COI

As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review ScientiaCME.

 

Faculty Disclosure:  Terry Schwartz, MD, has no relevant conflicts of interest to disclose.

 

Disclosures of Educational Planners: Charles Turck, PharmD has no relevant conflicts of interest to disclose.

 

Commercial Support Disclosure: This program is supported by an educational grant from Shire

 

 

Instructions

  • Read the learning objectives above
  • Take the Pre-Test (optional). Completion of the pre-test will help us evaluate the knowedge gained by participating in this CME activity.
  • View the online activity. You may view this is in more than one session, and may pause or repeat any portion of the presentation if you need to.
  • Take the post-test
  • Complete the activity evaluation and CME registration. A CE certificate will be emailed to you immediately.

Cultural and Linguistic Competence

System Requirements

PC
Windows 7 or above
Internet Explorer 8
*Adobe Acrobat Reader
MAC
Mac OS 10.2.8
Safari or Chrome or Firefox
*Adobe Acrobat Reader
Internet Explorer is not supported on the Macintosh

*Required to view Printable PDF Version


Perform Pre-Test (optional)

Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.


Additional Courses That Are Related To This Activity

Updates in the management of insomnia: Therapeutic updates and optimizing treatment

Attention Deficit Hyperactivity Disorder (ADHD) in Children and Adolescents: Updates from APA 2019

Attention Deficit Hyperactivity Disorder (ADHD) in Adults: Updates from APA 2019